Technical Analysis for RHHBF - Roche Holding AG

Grade Last Price % Change Price Change
grade A 276.6309 1.37% 3.7309
RHHBF closed up 1.37 percent on Tuesday, August 20, 2019, on 31 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical RHHBF trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.37%
Narrow Range Bar Range Contraction 1.37%
Down 3 Days in a Row Weakness 1.37%
Gapped Down Weakness 1.37%
Fell Below 20 DMA Bearish 1.13%
MACD Bearish Signal Line Cross Bearish 1.13%

Older signals for RHHBF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit roche.com
Health Pharmaceuticals Pharmaceutical Industry Life Sciences Diabetes Pharmaceutical Industry In China Infectious Diseases Chemotherapy Neuroscience Antibiotics In Vitro Diagnostics Genentech Hoffmann La Roche Diabetes Management Roche World Health Organization Personalised Healthcare Strategy Research Focused Healthcare Tissue Based Cancer
Is RHHBF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 285.0075
52 Week Low 214.46
Average Volume 654
200-Day Moving Average 248.611
50-Day Moving Average 270.2135
20-Day Moving Average 274.884
10-Day Moving Average 272.4791
Average True Range 3.9918
ADX 11.71
+DI 50.7727
-DI 43.1412
Chandelier Exit (Long, 3 ATRs ) 273.0321
Chandelier Exit (Short, 3 ATRs ) 276.9754
Upper Bollinger Band 286.9122
Lower Bollinger Band 262.8558
Percent B (%b) 0.57
BandWidth 8.751473
MACD Line 1.4454
MACD Signal Line 1.3809
MACD Histogram 0.0645
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 276.6309
Resistance 3 (R3) 276.6309 276.6309 276.6309
Resistance 2 (R2) 276.6309 276.6309 276.6309 276.6309
Resistance 1 (R1) 276.6309 276.6309 276.6309 276.6309 276.6309
Pivot Point 276.6309 276.6309 276.6309 276.6309 276.6309
Support 1 (S1) 276.6309 276.6309 276.6309 276.6309 276.6309
Support 2 (S2) 276.6309 276.6309 276.6309 276.6309
Support 3 (S3) 276.6309 276.6309 276.6309
Support 4 (S4) 276.6309